Trinity Biotech Announces A $45 Million Strategic Investment And Partnership With The MiCo Group of South Korea
11 avr. 2022 08h15 HE
|
Trinity Biotech plc
DUBLIN, Ireland, April 11, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading global diagnostic company (“Trinity Biotech” or the “Company”), today announced a $45 million...
Trinity Biotech Announces the World Health Organisation Approval Of TrinScreen™ HIV
14 févr. 2022 08h10 HE
|
Trinity Biotech plc
DUBLIN, Ireland, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) has received approval for its new HIV screening product, TrinScreen™ HIV, from the World Health Organisation...
Trinity Biotech Announces The Successful Closing of its Debt Refinancing
27 janv. 2022 17h05 HE
|
Trinity Biotech plc
DUBLIN, Ireland, Jan. 27, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory...
Trinity Biotech Announces That Its Shareholders Have Approved All of the Four Resolutions That Were the Subject of the EGM Held on January 25, 2022
25 janv. 2022 08h15 HE
|
Trinity Biotech plc
DUBLIN, Ireland, Jan. 25, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory...
Trinity Biotech Announces Q3 2021 Results, the Entry Into a $81,250,000 Loan Facility to Refinance the Company’s Exchangeable Senior Notes and Agreements To Repurchase Outstanding Exchangeable Senior Notes
15 déc. 2021 18h21 HE
|
Trinity Biotech plc
DUBLIN, Dec. 15, 2021 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical...
Trinity Biotech Announces Results for Q2, 2021
09 sept. 2021 08h45 HE
|
Trinity Biotech plc
DUBLIN, Ireland, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory...
Trinity Biotech plc to Announce Second Quarter Fiscal Year 2021 Financial Results
31 août 2021 16h30 HE
|
Trinity Biotech plc
DUBLIN, Ireland, Aug. 31, 2021 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory...
Trinity Biotech Provides A Business Development Update For Q2 2021
16 juil. 2021 08h00 HE
|
Trinity Biotech plc
DUBLIN, Ireland, July 16, 2021 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) provides a business development update for Q2 2021. HIV Testing (TrinScreen™ HIV) Trinity Biotech has been the...
Trinity Biotech Announces Results for Q1, 2021
25 mai 2021 08h48 HE
|
Trinity Biotech plc
DUBLIN, Ireland, May 25, 2021 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory...
Trinity Biotech plc to Announce First Quarter Fiscal Year 2021 Financial Results
19 mai 2021 12h43 HE
|
Trinity Biotech plc
DUBLIN, Ireland, May 19, 2021 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory...